Insilico advances virtual cell research
Insilico Medicine has introduced biological age as a core condition in virtual cell research with the launch of its Virtual Aging Cell (VAC) Webpage and a preview of its Multi-Agent driven VAC platform. The clinical-stage drug discovery company said the platform represents the industry’s first multi-agent Virtual Aging Cell platform… Read More